Sign Out
Careful Administration (Transamin should be administered with care in the following patients): (1) Patients with thrombosis (e.g. cerebral thrombosis, myocardial infarction or thrombophlebitis, etc.) and patients at risk of thrombosis [Transamin may stabilize thrombosis].
(2) Patients with consumption coagulopathy (Use concomitantly with heparin, etc.) [Transamin may stabilize thrombosis].
(3) Postoperative, recumbent ridden patients and patients undergoing astriction [Venous thrombosis is likely to occur in these patients and Transamin may stabilize thrombosis. Pulmonary embolism has been reported in association with resolution of recumbency or removal of astriction].
(4) Patients with renal failure [Blood concentration may increase].
(5) Patients with a history of hypersensitivity to any of the components of this product.
Precautions concerning Use: For drugs that are dispensed in a press-through package (PTP), instruct the patient to remove the drug from the package prior to use. [It has been reported that, if the PTP sheet is swallowed, the sharp corners of the sheet may puncture the esophageal mucosa, resulting in severe complications such as mediastinitis.]
Other Precautions: Retinal degeneration has been reported with tranexamic acid in dogs after long-term, high-dose administration.
Use in Pregnancy & Lactation: No safety information.
Use in the Elderly: Since elderly patients often have reduced physiological function, careful supervision and measures such as reducing the dose are recommended.
